메뉴 건너뛰기




Volumn 70, Issue 14, 2010, Pages 1540-1546

Glycemic control and prostate cancer progression: Results from the SEARCH database

Author keywords

Diabetes; Hba1c; Prostate cancer

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

EID: 77957013460     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21189     Document Type: Article
Times cited : (35)

References (24)
  • 3
    • 0029017953 scopus 로고
    • Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
    • Everhart J, Wright D,. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995; 273 (20): 1605 -1609.
    • (1995) JAMA , vol.273 , Issue.20 , pp. 1605-1609
    • Everhart, J.1    Wright, D.2
  • 4
    • 33750930105 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of bladder cancer: A meta-analysis
    • Larsson SC, Orsini N, Brismar K, Wolk A,. Diabetes mellitus and risk of bladder cancer: A meta-analysis. Diabetologia 2006; 49 (12): 2819 -2823.
    • (2006) Diabetologia , vol.49 , Issue.12 , pp. 2819-2823
    • Larsson, S.C.1    Orsini, N.2    Brismar, K.3    Wolk, A.4
  • 5
    • 34249948987 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of endometrial cancer: A meta-analysis
    • DOI 10.1007/s00125-007-0681-5
    • Friberg E, Orsini N, Mantzoros CS, Wolk A,. Diabetes mellitus and risk of endometrial cancer: A meta-analysis. Diabetologia 2007; 50 (7): 1365 -1374. (Pubitemid 46879010)
    • (2007) Diabetologia , vol.50 , Issue.7 , pp. 1365-1374
    • Friberg, E.1    Orsini, N.2    Mantzoros, C.S.3    Wolk, A.4
  • 6
    • 34547127614 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of breast cancer: A meta-analysis
    • DOI 10.1002/ijc.22717
    • Larsson SC, Mantzoros CS, Wolk A,. Diabetes mellitus and risk of breast cancer: A meta-analysis. Int J Cancer 2007; 121 (4): 856 -862. (Pubitemid 47106217)
    • (2007) International Journal of Cancer , vol.121 , Issue.4 , pp. 856-862
    • Larsson, S.C.1    Mantzoros, C.S.2    Wolk, A.3
  • 7
    • 27944450832 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of colorectal cancer: A meta-analysis
    • DOI 10.1093/jnci/dji375
    • Larsson SC, Orsini N, Wolk A,. Diabetes mellitus and risk of colorectal cancer: A meta-analysis. J Natl Cancer Inst 2005; 97 (22): 1679 -1687. (Pubitemid 41672234)
    • (2005) Journal of the National Cancer Institute , vol.97 , Issue.22 , pp. 1679-1687
    • Larsson, S.C.1    Orsini, N.2    Wolk, A.3
  • 9
    • 3142729250 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of prostate cancer: A meta-analysis
    • Bonovas S, Filioussi K, Tsantes A,. Diabetes mellitus and risk of prostate cancer: A meta-analysis. Diabetologia 2004; 47 (6): 1071 -1078.
    • (2004) Diabetologia , vol.47 , Issue.6 , pp. 1071-1078
    • Bonovas, S.1    Filioussi, K.2    Tsantes, A.3
  • 10
    • 33845328853 scopus 로고    scopus 로고
    • A meta-analysis of diabetes mellitus and the risk of prostate cancer
    • DOI 10.1158/1055-9965.EPI-06-0410
    • Kasper JS, Giovannucci E,. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15 (11): 2056 -2062. (Pubitemid 44877026)
    • (2006) Cancer Epidemiology Biomarkers and Prevention , vol.15 , Issue.11 , pp. 2056-2062
    • Kasper, J.S.1    Giovannucci, E.2
  • 11
    • 70350433657 scopus 로고    scopus 로고
    • The protective effect of diabetes mellitus against prostate cancer: Role of sex hormones
    • Baradaran N, Ahmadi H, Salem S, Lotfi M, Jahani Y, Mehrsai AR, Pourmand G,. The protective effect of diabetes mellitus against prostate cancer: Role of sex hormones. Prostate 2009; 69 (16): 1744 -1750.
    • (2009) Prostate , vol.69 , Issue.16 , pp. 1744-1750
    • Baradaran, N.1    Ahmadi, H.2    Salem, S.3    Lotfi, M.4    Jahani, Y.5    Mehrsai, A.R.6    Pourmand, G.7
  • 12
    • 60549106435 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
    • Kasper JS, Liu Y, Giovannucci E,. Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 2009; 124 (6): 1398 -1403.
    • (2009) Int J Cancer , vol.124 , Issue.6 , pp. 1398-1403
    • Kasper, J.S.1    Liu, Y.2    Giovannucci, E.3
  • 14
    • 23844528527 scopus 로고    scopus 로고
    • History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States)
    • Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR,. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control 2005; 16 (7): 789 -797.
    • (2005) Cancer Causes Control , vol.16 , Issue.7 , pp. 789-797
    • Chan, J.M.1    Latini, D.M.2    Cowan, J.3    Duchane, J.4    Carroll, P.R.5
  • 15
    • 74549196089 scopus 로고    scopus 로고
    • Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database
    • Jayachandran J, Aronson WJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Freedland SJ,. Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. Cancer Epidemiol Biomarkers Prev 2010; 19 (1): 9 -17.
    • (2010) Cancer Epidemiol Biomarkers Prev , vol.19 , Issue.1 , pp. 9-17
    • Jayachandran, J.1    Aronson, W.J.2    Terris, M.K.3    Presti, Jr.J.C.4    Amling, C.L.5    Kane, C.J.6    Freedland, S.J.7
  • 16
    • 65549118658 scopus 로고    scopus 로고
    • Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer
    • Hong SK, Lee ST, Kim SS, Min KE, Byun SS, Cho SY, Choe G, Lee SE,. Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer. Prostate 2009; 69 (8): 820 -826.
    • (2009) Prostate , vol.69 , Issue.8 , pp. 820-826
    • Hong, S.K.1    Lee, S.T.2    Kim, S.S.3    Min, K.E.4    Byun, S.S.5    Cho, S.Y.6    Choe, G.7    Lee, S.E.8
  • 17
    • 48149094205 scopus 로고    scopus 로고
    • Hormonal profile of diabetic men and the potential link to prostate cancer
    • Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E,. Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control 2008; 19 (7): 703 -710.
    • (2008) Cancer Causes Control , vol.19 , Issue.7 , pp. 703-710
    • Kasper, J.S.1    Liu, Y.2    Pollak, M.N.3    Rifai, N.4    Giovannucci, E.5
  • 18
    • 33644981693 scopus 로고    scopus 로고
    • Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis
    • Ding EL, Song Y, Malik VS, Liu S,. Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2006; 295 (11): 1288 -1299.
    • (2006) JAMA , vol.295 , Issue.11 , pp. 1288-1299
    • Ding, E.L.1    Song, Y.2    Malik, V.S.3    Liu, S.4
  • 19
    • 55449101667 scopus 로고    scopus 로고
    • Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction
    • El-Sakka AI, Sayed HM, Tayeb KA,. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl 2008; 31 (6): 602 -608.
    • (2008) Int J Androl , vol.31 , Issue.6 , pp. 602-608
    • El-Sakka, A.I.1    Sayed, H.M.2    Tayeb, K.A.3
  • 20
    • 33745684473 scopus 로고    scopus 로고
    • Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
    • Kapoor D, Goodwin E, Channer KS, Jones TH,. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006; 154 (6): 899 -906.
    • (2006) Eur J Endocrinol , vol.154 , Issue.6 , pp. 899-906
    • Kapoor, D.1    Goodwin, E.2    Channer, K.S.3    Jones, T.H.4
  • 21
    • 0033950926 scopus 로고    scopus 로고
    • Is low serum free testosterone a marker for high grade prostate cancer?
    • Hoffman MA, DeWolf WC, Morgentaler A,. Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000; 163 (3): 824 -827.
    • (2000) J Urol , vol.163 , Issue.3 , pp. 824-827
    • Hoffman, M.A.1    Dewolf, W.C.2    Morgentaler, A.3
  • 23
    • 18744369944 scopus 로고    scopus 로고
    • Testosterone as a predictor of pathological stage in clinically localized prostate cancer
    • Isom-Batz G, Bianco FJ Jr, Kattan MW, Mulhall JP, Lilja H, Eastham JA,. Testosterone as a predictor of pathological stage in clinically localized prostate cancer. J Urol 2005; 173 (6): 1935 -1937.
    • (2005) J Urol , vol.173 , Issue.6 , pp. 1935-1937
    • Isom-Batz, G.1    Bianco, Jr.F.J.2    Kattan, M.W.3    Mulhall, J.P.4    Lilja, H.5    Eastham, J.A.6
  • 24
    • 13844299328 scopus 로고    scopus 로고
    • Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy
    • Imamoto T, Suzuki H, Fukasawa S, Shimbo M, Inahara M, Komiya A, Ueda T, Shiraishi T, Ichikawa T,. Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy. Eur Urol 2005; 47 (3): 308 -312.
    • (2005) Eur Urol , vol.47 , Issue.3 , pp. 308-312
    • Imamoto, T.1    Suzuki, H.2    Fukasawa, S.3    Shimbo, M.4    Inahara, M.5    Komiya, A.6    Ueda, T.7    Shiraishi, T.8    Ichikawa, T.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.